We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:

Search Results

Showing 1-20 of 7,046 results
  1. Naloxone

    Reference work entry 2024
  2. PBPK-PD model for predicting morphine pharmacokinetics, CNS effects and naloxone antagonism in humans

    Morphine and morphine-6-glucuronide (M6G) produce central nervous system (CNS) effects by activating mu-opioid receptors, while naloxone is used...

    Rui-jing Mu, Tian-lei Liu, ... Li Liu in Acta Pharmacologica Sinica
    Article 03 April 2024
  3. Prediction of naloxone dose in opioids toxicity based on machine learning techniques (artificial intelligence)

    Background

    Treatment management for opioid poisoning is critical and, at the same time, requires specialized knowledge and skills. This study was...

    Seyed Ali Mohtarami, Babak Mostafazadeh, ... Hamidreza Eskandari in DARU Journal of Pharmaceutical Sciences
    Article 21 May 2024
  4. Re-examining Naloxone Pharmacokinetics After Intranasal and Intramuscular Administration Using the Finite Absorption Time Concept

    Background and Objectives

    Naloxone for opioid overdose treatment can be administered by intravenous injection, intramuscular injection, or intranasal...

    Athanasios A. Tsekouras, Panos Macheras in European Journal of Drug Metabolism and Pharmacokinetics
    Article 02 June 2023
  5. Teneurin C-terminal associated peptide (TCAP)-1 attenuates the development and expression of naloxone-precipitated morphine withdrawal in male Swiss Webster mice

    Rationale

    Corticotropin-releasing factor (CRF), the apical stress-inducing hormone, exacerbates stress and addictive behaviors. TCAP-1 is a peptide...

    Lauren E. Mueller, Roseanne S. Wexler, ... Andrew M. Slee in Psychopharmacology
    Article Open access 17 April 2024
  6. Inhibition of the NLRP3 Inflammasome Activation/Assembly through the Activation of the PI3K Pathway by Naloxone Protects Neural Stem Cells from Ischemic Condition

    Naloxone is a well-known opioid antagonist and has been suggested to have neuroprotective effects in cerebral ischemia. We investigated whether...

    Ji Young Kim, Mina Hwang, ... Seong-Ho Koh in Molecular Neurobiology
    Article 10 June 2023
  7. A low dose of naloxone mitigates autoimmune hepatitis by regulating TLR4/NF-κB and Nrf2/HO-1 signaling pathways

    Naloxone is a non-selective opiate receptor antagonist that is mainly used in the management of acute opioid overdose or intoxication. Previously,...

    Kawther Magdy Ibrahim, Hebatalla I. Ahmed, ... Amany Balah in Inflammopharmacology
    Article Open access 03 September 2023
  8. A Novel Faster-Acting, Dry Powder-Based, Naloxone Intranasal Formulation for Opioid Overdose

    Objective

    To examine the pharmacokinetics and safety of FMXIN001, a new intranasal powder-based naloxone formulation, in comparison to Narcan® nasal...

    Tair Lapidot, Mohammed Bouhajib, ... Dalia Megiddo in Pharmaceutical Research
    Article Open access 06 April 2022
  9. Naloxone and nalmefene absorption delivered by hollow microneedles compared to intramuscular injection

    Naloxone and nalmefene were administered to seven research beagle dogs (mean weight approximately 12 kg) at doses of 0.04 mg/kg and 0.014 mg/kg for...

    Mark G. Papich, Roger J. Narayan in Drug Delivery and Translational Research
    Article 24 November 2021
  10. Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid Overdose

    Purpose

    Opioids have been the main factor for drug overdose deaths in the United States. Current naloxone delivery systems are effective in mitigating...

    Farrokh Sharifi, Yazan J. Meqbil, ... Kinam Park in Pharmaceutical Research
    Article 10 June 2021
  11. The pharmacokinetic interaction between nasally administered naloxone and the opioid remifentanil in human volunteers

    Purpose

    Remifentanil has been shown to increase the bioavailability of nasally administered naloxone. The aim of this study was to explore the nature...

    Ida Tylleskar, Sissel Skarra, ... Ola Dale in European Journal of Clinical Pharmacology
    Article Open access 29 July 2021
  12. Prolonged morphine exposure during adolescence alters the responses of lateral paragigantocellularis neurons to naloxone in adult morphine dependent rats

    Introduction

    Adolescence is a critical period in brain development, and it is characterized by persistent maturational alterations in the function of...

    Sara Sabuee, S. Mohammad Ahmadi-Soleimani, Hossein Azizi in The Journal of Physiological Sciences
    Article Open access 24 August 2021
  13. Pentylenetetrazol-like stimulus is not produced following naloxone-precipitated mitragynine withdrawal in rats

    Rationale

    Kratom ( Mitragyna speciosa Korth), a native medicinal plant of Southeast Asia, is proposed to exhibit potential therapeutic value as an...

    Illa S. Johari, Norsyifa Harun, ... Mohammed Shoaib in Psychopharmacology
    Article 01 August 2021
  14. The effects of naloxone, diazepam, and quercetin on seizure and sedation in acute on chronic tramadol administration: an experimental study

    Background

    Tramadol is a widely used synthetic opioid. Substantial research has previously focused on the neurological effects of this drug, while the...

    Samaneh Nakhaee, Khadijeh Farrokhfall, ... Omid Mehrpour in Behavioral and Brain Functions
    Article Open access 29 May 2021
  15. Mechanistic modeling-guided optimization of microneedle-based skin patch for rapid transdermal delivery of naloxone for opioid overdose treatment

    Naloxone, an FDA-approved opioid inhibitor, used to reverse opioid overdose complications has up till date faced challenges associated with its...

    Akeemat Tijani, Prashant Dogra, ... Ashana Puri in Drug Delivery and Translational Research
    Article 25 July 2022
  16. Divergent Electrophysiological Effects of Loperamide and Naloxone in a Sensitive Whole-Heart Model

    Several case reports suggest QT prolongation leading to ventricular arrhythmias with fatal outcome after intoxication with the μ-opioid receptor...

    Julian Wolfes, Christian Ellermann, ... Gerrit Frommeyer in Cardiovascular Toxicology
    Article 30 October 2020
  17. Naloxone Facilitates Contextual Learning and Memory in a Receptor-Independent and Tet1-Dependent Manner

    Opioids, like morphine and naloxone, regulate the proliferation and neuronal differentiation of neural stem cells (NSCs) in a receptor-independent...

    Fei Meng, Yuan Li, ... Hui Zheng in Cellular and Molecular Neurobiology
    Article 28 September 2020
  18. Naloxone Diminishes the Virulence and Modifies the Cellular Immune Responses of BALB/c Mice Infected with Leishmania major

    Purpose

    Leishmania major -infected BALB/c mice display strong susceptibility to the infection due to the induction of Th2 response. The aim of this...

    Mohammad Hossein Alimohammadian, Farhad Riazi-Rad, ... Soheila Ajdary in Acta Parasitologica
    Article 19 November 2020
Did you find what you were looking for? Share feedback.